Global Sleep Movement Disorders Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Drug Class;

Benzodiazepines, Opioids, Dopaminergic Agonists, Anticonvulsants, and Others.

By Types Of Sleep Movement Disorders;

Restless Legs Syndrome, Periodic Limb Movement Disorder (PLMD), Sleep Leg Cramps, Sleep Rhythmic Movement, and Sleep Bruxism.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn629225226 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Sleep Movement Disorders Market (USD Million), 2021 - 2031

In the year 2024, the Global Sleep Movement Disorders Market was valued at USD 1159.17 million. The size of this market is expected to increase to USD 1742.97 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.0%.

The Global Sleep Movement Disorders Market is witnessing significant growth, driven by the increasing prevalence of sleep disorders such as restless legs syndrome (RLS) and periodic limb movement disorder (PLMD). These conditions are becoming more commonly diagnosed due to rising awareness among both patients and healthcare professionals about the importance of sleep health. The growing geriatric population, who are more susceptible to sleep disorders, is also contributing to the market expansion. Technological advancements in diagnostic tools and treatments, including polysomnography and innovative drug therapies, are enhancing the ability to effectively diagnose and manage these conditions, further propelling market growth.

The increasing incidence of lifestyle-related factors such as stress, sedentary behavior, and poor sleep hygiene, particularly in urban areas, is exacerbating the prevalence of sleep movement disorders. The market is also benefiting from the expanding healthcare infrastructure in emerging economies, which is making advanced diagnostic and treatment options more accessible. Pharmaceutical companies and medical device manufacturers are investing heavily in research and development to introduce new products and therapies, aiming to capture a larger share of this burgeoning market. Favorable reimbursement policies and the growing number of sleep clinics are expected to support sustained market growth in the coming years.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Class
    2. Market Snapshot, By Types Of Sleep Movement Disorders
    3. Market Snapshot, By Region
  4. Global Sleep Movement Disorders Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing sleep disorder cases globally
        2. Primary healthcare integrating sleep disorder management
        3. Growing awareness of sleep's impact on health
        4. Advanced diagnostic technologies
      2. Restraints
        1. Stigma and misconceptions
        2. Patient adherence challenges
        3. Lifestyle impacts like shift work
      3. Opportunities
        1. Personalized medicine development
        2. Telemedicine expansion
        3. AI-driven diagnostics
        4. Holistic management approaches
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Sleep Movement Disorders Market, By Drug Class, 2021 - 2031 (USD Million)
      1. Benzodiazepines
      2. Opioids
      3. Dopaminergic Agonists
      4. Anticonvulsants
      5. Others
    2. Global Sleep Movement Disorders Market, By Types Of Sleep Movement Disorders, 2021 - 2031 (USD Million)
      1. Restless Legs Syndrome
      2. Periodic Limb Movement Disorder (PLMD)
      3. Sleep Leg Cramps
      4. Sleep Rhythmic Movement
      5. Sleep Bruxism
    3. Global Sleep Movement Disorders Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape Analysis
    1. Company Profiles
      1. Cardinal Health, Inc.
      2. Mylan N.V.
      3. Teva Pharmaceutical Industries Ltd.
      4. Apotex Corporation
      5. Egalet Corporation
      6. Allergan plc
      7. Pfizer Inc.
  7. Analyst Views
  8. Future Outlook of the Market